SYNAPTICS SYNA
- Market cap
- $4.6B
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 3.8×
- EV/EBIT
- n/m
- a loss over the last year
- Revenue, 12 months
- $1.2B
- +11% on a year ago
- Net margin
- −41.0%
- Free cash flow yield
- 2.2%
SYNAPTICS trades at 3.8× sales. Its trailing earnings are negative, so it has no PE. Revenue was $1.2B over the last twelve months, up 11% on a year earlier with a −41% net margin.
Charts
Financials
| Income statement | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $237.7M−47% | $237M−33% | $237.3M−27% | $247.4M+9% | $257.7M+8% | $267.2M+13% | $266.6M+12% | $282.8M+14% | $292.5M+14% | $302.5M+13% | $294.2M+10% | $308M+9% | |
| Cost of revenue | $130.6M−32% | $128M−23% | $127M−18% | $134M+6% | $136.8M+5% | $145M+13% | $150.8M+19% | $161.3M+20% | $167.9M+23% | $170.8M+18% | $160.9M+7% | $162.2M+1% |
| Gross profit | $107.1M−58% | $109M−42% | $110.3M−36% | $113.4M+12% | $120.9M+13% | $122.2M+12% | $115.8M+5% | $121.5M+7% | $124.6M+3% | $131.7M+8% | $133.3M+15% | $145.8M+20% |
| R&D | $86.5M−3% | $82M−8% | $83.4M−5% | $84.4M−0% | $81.3M−6% | $83.3M+2% | $88.6M+6% | $93.6M+11% | $94.4M+16% | $95.1M+14% | $94.5M+7% | $97.8M+5% |
| SG&A | $42.3M−5% | $39.7M−6% | $40.5M−3% | $38.8M−16% | $50M+18% | $49.5M+25% | $34.7M−14% | $46.1M+19% | $46.2M−8% | $47.8M−3% | $49.6M+43% | $54.7M+19% |
| −$35.2M | −$17.9M | −$17.4M | −$31.1M−18% | −$28.4M−19% | −$15.2M−15% | −$26.3M+51% | −$24.2M−22% | −$23.2M−18% | −$15.1M−1% | −$12.7M−52% | −$16.1M−34% | |
| Interest expense | $5.4M−22% | $6.1M−25% | $5.9M−48% | $47.9M+65% | $5.9M+9% | $4.3M−30% | $1.1M−81% | $28.5M−41% | n/a | $2.4M−44% | $2.5M+127% | $19M−33% |
| Pre-tax income | −$40.6M | −$24M | −$23.3M | −$36.7M−17% | −$34.3M−16% | −$26M+8% | −$27.4M+18% | −$25.8M−30% | −$22.7M−34% | −$17.5M−33% | −$15.2M−45% | −$24M−7% |
| $15M−62% | −$15M | −$5.2M | −$245M+1072% | −$11.2M | −$27.8M+85% | −$5.6M+8% | −$21.1M−91% | −$2.1M−81% | −$2.7M−90% | −$7.2M+29% | $423.4M | |
| Net income | −$55.6M | −$9M | −$18.1M | $208.3M | −$23.1M−59% | $1.8M | −$21.8M+20% | −$4.7M | −$20.6M−11% | −$14.8M | −$8M−63% | −$447.4M+9419% |
| −$1.43 | −$0.23 | −$0.46 | $5.21 | −$0.58−59% | $0.05 | −$0.56+22% | −$0.12 | −$0.53−9% | −$0.38 | −$0.21−63% | −$11.50+9483% | |
| 38.8M−5% | 39.2M−3% | 39.3M−2% | 40M+2% | 39.8M+3% | 39.8M+2% | 39M−1% | 38.7M−3% | 38.8M−3% | 38.9M−2% | 38.8M−1% | 38.9M+1% |
EPS, diluted: 10 periods, Q4 FY10 to Q4 FY26: quarter's net income to common over its shares, to the cent.
Diluted shares: 4 periods, Q4 FY10 to Q4 FY22: share-days: the 12-month average less the 9-month, weighted by days. 5 periods, Q4 FY18 to Q4 FY26: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. Q4 FY24: the earlier year to date counted no dilution: the quarter's basic count plus the later year to date's dilution.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Semiconductors nearest SYNAPTICS' size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| SYNASYNAPTICS | $4.6B | n/m | 21.5× | 3.8× | +11% | −41.0% | |
| ENPHEnphase Energy | $4.2B | 31.9× | 74.6× | 3.1× | −10% | 10.1% | |
| KLICKulicke & Soffa Industries | $3.9B | 34.0× | 26.5× | 4.1× | +44% | 12.2% | |
| CRUSCirrus Logic | $5.6B | 13.7× | 21.2× | 2.7× | +6% | 21.0% | |
| DIODDiodes | $3.7B | 43.8× | 30.7× | 2.3× | +18% | 5.3% | |
| ACMRACM Research | $3.5B | 24.0× | 26.0× | 3.4× | +27% | 14.5% | |
| ACLSAxcelis Technologies | $3.3B | 35.8× | 23.1× | 3.8× | −3% | 10.7% | |
| PENGPenguin Solutions | $3.2B | 22.0× | 69.8× | 1.9× | +26% | 10.4% | |
| OSISOSI Systems | $3.1B | 21.9× | 24.7× | 1.8× | +4% | 8.7% | |
| IPGPIPG Photonics | $3B | 109× | 32.6× | 2.8× | +13% | 2.6% | |
| FORMFormfactor | $7.7B | 67.5× | 40.5× | 8.5× | +18% | 12.8% | |
| Peer median | $3.6B | 32.9× | 28.6× | 3.0× | +15% | 10.6% |
More on SYNAPTICS
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Its groups
About
- Industry
- Semiconductors
- Sector
- Technology
Valuation data, not investment advice. Prices as of .